CRP and COVID-19: In patients with diabetes who present with COVID-19, the inflammatory marker C-reactive protein (CRP) has been identified as one of the strongest risk factors for mortality [2], while patients with prolonged hyperglycemia have higher IL-6 and D-dimer levels and a higher risk of progressing to severe disease [16].